APA (7th ed.) Citation

Kakavandi, E., Sadeghi, K., Shayestehpour, M., Mirhendi, H., Rahimi Foroushani, A., Mokhtari-Azad, T., . . . Yavarian, J. (2024). Evaluation of angiotensin converting enzyme 2 (ACE2), angiotensin II (Ang II), miR-141-3p, and miR-421 levels in SARS-CoV-2 patients: A case-control study. BMC Infectious Diseases, 24(1), 1. https://doi.org/10.1186/s12879-024-09310-3

Chicago Style (17th ed.) Citation

Kakavandi, Ehsan, Kaveh Sadeghi, Mohammad Shayestehpour, Hossein Mirhendi, Abbas Rahimi Foroushani, Talat Mokhtari-Azad, Nazanin Zahra Shafiei Jandaghi, and Jila Yavarian. "Evaluation of Angiotensin Converting Enzyme 2 (ACE2), Angiotensin II (Ang II), MiR-141-3p, and MiR-421 Levels in SARS-CoV-2 Patients: A Case-control Study." BMC Infectious Diseases 24, no. 1 (2024): 1. https://doi.org/10.1186/s12879-024-09310-3.

MLA (9th ed.) Citation

Kakavandi, Ehsan, et al. "Evaluation of Angiotensin Converting Enzyme 2 (ACE2), Angiotensin II (Ang II), MiR-141-3p, and MiR-421 Levels in SARS-CoV-2 Patients: A Case-control Study." BMC Infectious Diseases, vol. 24, no. 1, 2024, p. 1, https://doi.org/10.1186/s12879-024-09310-3.